NEW YORK (AP) -- Shares of Biopharmaceutical company MannKind Corp. fell Monday over concerns it could take the company longer than expected to find a development and sales partner for its inhalable insulin candidate.
NEW YORK (AP) -- Shares of Biopharmaceutical company MannKind Corp. fell Monday over concerns it could take the company longer than expected to find a development and sales partner for its inhalable insulin candidate.